Article Details

Pfizer says hemophilia B gene therapy controlled bleeding in key study | BioPharma Dive

Retrieved on: 2022-12-29 18:54:50

Tags for this article:

Click the tags to see associated articles and topics

Pfizer says hemophilia B gene therapy controlled bleeding in key study | BioPharma Dive. View article details on HISWAI: https://www.biopharmadive.com/news/pfizer-hemophilia-b-gene-therapy-spark-bleeding/639477/

Excerpt

A single dose of Pfizer's therapy, called fidanacogene elaparvovec, lowered participants' annual bleeding rates by an average of 71% over one year, ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up